Major owner of LianBio was just granted 72,000 options

Advisors Llc Perceptive, a major owner of LianBio and a director of the company, just received 72,000 options from the company. The strike price of the options received was $2.52, and these expire on June 23, 2032. Perceptive now owns at least 72,000 options on the company.

Some additional info was provided as follows:


The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to Konstantin Poukalov providing continuous service to the Issuer through such date.
The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to Adam Stone providing continuous service to the Issuer through such date.< br>Consists of options to purchase shares of the Issuer's ordinary shares awarded to Adam Stone in connection with his role as a member of the Issuer's Board of Directors. Mr. Stone is the Chief Investment Officer of Perceptive Advisors, LLC (the "Advisor"). The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Stone's board service through a partial management fee offset.
Consists of options to purchase shares of the Issuer's ordinary shares awarded to Konstantin Poukalov in connection with his role as a member of the Issuer's Board of Directors. Mr. Poukalov is affiliated with the Advisor. The Advisor may be deemed to have an indirect pecuniary interest in the options to purchase ordinary shares of the Issuer reported herein because the Advisor has the right to receive the director compensation provided in respect of Mr. Poukalov's board service through a partial management fee offset.
Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this form, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever LianBio makes a similar move, sign up!

Auto Refresh

Feedback